FLGT
ANALYST COVERAGE9 analysts
BUY
-6.8%downside to target
Buy
667%
Hold
333%
6 Buy (67%)3 Hold (33%)0 Sell (0%)
Full report →
PRICE
Prev Close
15.85
Open
15.80
Day Range15.62 – 16.20
15.62
16.20
52W Range13.46 – 31.04
13.46
31.04
15% of range
VOLUME & SIZE
Avg Volume
667.2K
FUNDAMENTALS
P/E Ratio
-6.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.16
Market-like
TECHNICAL
RSI (14)
31
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 104 days
Aug 31
Key MetricsTTM
Market Cap$450.15M
Revenue TTM$320.35M
Net Income TTM-$73.81M
Free Cash Flow-$113.17M
Gross Margin38.1%
Operating Margin-33.1%
Net Margin-23.0%
Return on Equity-6.7%
Return on Assets-6.4%
Debt / Equity0.01
Current Ratio5.31
EPS TTM$-2.39

FLGT News

About

mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques

CEO
Ming Hsieh
Hanlin Gao FACMGChief Scientific Officer & Laboratory Director
Ray YinPresident & Chief Scientific Officer of Fulgent Pharma
Brandon PerthuisChief Commercial Officer
Ellen TsuiVice President of Human Resources
Elias NyankojoChief Information Security Officer
Jakub SramVice President of Business Development & Sales
Jian XieChief Operating Officer & President
Ming HsiehChairman & Chief Executive Officer
Paul KimChief Financial Officer
Doreen NgVice President of Operations & Compliance
Natalie PrescottGeneral Counsel & Chief Privacy Officer